Selective gene therapy for proliferative disorders: Sense and antisense
- 1 June 1996
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 2 (6) , 634-635
- https://doi.org/10.1038/nm0696-634
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinaseNature Medicine, 1996
- Requirement for cAMP-PKA Pathway Activation by M Phase-Promoting Factor in the Transition from Mitosis to InterphaseScience, 1996
- Does antisense exist?Nature Medicine, 1995
- The state of the art in antisense researchNature Medicine, 1995
- OncogenesNew England Journal of Medicine, 1995
- Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivoNature Medicine, 1995
- Cascading towards vascular disorder gene therapyNature Medicine, 1995
- A ‘senseless’ immune response to DNANature Medicine, 1995
- Selective Inhibition of ras -Dependent Transformation by a Farnesyltransferase InhibitorScience, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993